Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02206802 · ClinicalTrials.gov registry record

Minoxidil Response Testing in Females With Female Pattern Hair Loss

A clinical trial of Alopecia and Female Pattern Hair Loss, sponsored by Applied Biology.

Completed
Registry status
300
Enrollment target
5
Study locations

NCT02206802 is a study of Alopecia and Female Pattern Hair Loss that has completed, run by Applied Biology. The registered enrollment target is 300 participants, above the 102-participant average among 13 other Alopecia trials with a reported enrollment target (194% higher). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02206802, a study of Alopecia and Female Pattern Hair Loss, has completed, sponsored by Applied Biology.

COMPLETED
Registry status
300 participants
Enrollment target
5
Study locations

Study Summary

The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.

Interventions

  • DRUG 5% minoxidil topical foam

Study Locations (5)

Other

  • Sinclair Dermatology - East Melbourne
  • LTM Medical College & Hospital - Mumbai
  • Istituto Medico Tricologico/Studi Life Cronos - Florence

Arizona

  • Physicians Hair Institute - Tucson

Tennessee

  • Tennessee Clinical Research Center - Nashville

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2014-07
Est. Completion 2018-10

Sponsor

Applied Biology

6 total trials

What the Registry Record Tells You About NCT02206802

The ClinicalTrials.gov registry entry for NCT02206802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 102-participant average among 13 other Alopecia trials with a reported enrollment target (194% higher). The listed sponsor is Applied Biology, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alopecia appearing as the primary indexed condition, and to 1 intervention - of which 5% minoxidil topical foam is the first listed.

NCT02206802 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Other, Arizona, Tennessee.

Frequently Asked Questions

What is clinical trial NCT02206802 about?

NCT02206802 is a clinical study titled "Minoxidil Response Testing in Females With Female Pattern Hair Loss". The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.

What is the current status of trial NCT02206802?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2014-07. Estimated completion is 2018-10.

What conditions does trial NCT02206802 study?

This clinical trial studies the following conditions: Alopecia, Female Pattern Hair Loss.

What interventions are being tested in trial NCT02206802?

The interventions under investigation include: 5% minoxidil topical foam (DRUG).

Who is sponsoring clinical trial NCT02206802?

This trial is sponsored by Applied Biology, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02206802 being conducted?

This trial has 5 study locations across Arizona, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alopecia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.